Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited11.804414194524.9426
Domestic EquitiesDivi's Laboratories Limited8.77313117118.5374
Domestic EquitiesApollo Hospitals Enterprise Limited6.59531878413.9358
Domestic EquitiesMax Healthcare Institute Limited5.497912072111.6170
Domestic EquitiesTorrent Pharmaceuticals Limited5.28192644611.1607
Domestic EquitiesAurobindo Pharma Limited4.99158085810.5471
Domestic EquitiesLupin Limited4.1993383478.8731
Domestic EquitiesLaurus Labs Limited3.6492776757.7108
Domestic EquitiesAlkem Laboratories Limited3.1230124536.5988
Domestic EquitiesFortis Healthcare Limited2.9148774716.1589
Domestic EquitiesNeuland Laboratories Limited2.658146705.6166
Domestic EquitiesAster DM Healthcare Limited2.3229732574.9082
Domestic EquitiesAbbott India Limited2.318018904.8979
Domestic EquitiesGlenmark Pharmaceuticals Limited2.1485212964.5397
Domestic EquitiesCohance Lifesciences Limited2.08681462714.4093
Domestic EquitiesDr. Reddy's Laboratories Limited1.8728315343.9572
Domestic EquitiesMankind Pharma Limited1.8538195293.9171
Domestic EquitiesSai Life Sciences Limited1.8214395953.8486
Domestic EquitiesIPCA Laboratories Limited1.7041224883.6008
Domestic EquitiesCipla Limited1.6681287923.5247
Domestic EquitiesPark Medi World Limited1.49401660943.1568
Domestic EquitiesLinde India Limited1.391242952.9395
Domestic EquitiesBiocon Limited1.2930757062.7322
Domestic EquitiesSBI Life Insurance Company Limited1.2474148302.6357
Domestic EquitiesHealthcare Global Enterprises Limited1.2444500662.6295
Domestic EquitiesSumitomo Chemical India Limited1.2101701582.5569
Domestic EquitiesFDC Limited1.1576761792.4461
Domestic EquitiesOnesource Specialty Pharma Limited1.1476164592.4249
Domestic EquitiesRainbow Childrens Medicare Limited1.1091201502.3436
Domestic EquitiesShaily Engineering Plastics Limited1.1078112302.3408
Domestic EquitiesPiramal Pharma Limited1.09951701522.3233
Domestic EquitiesJubilant Ingrevia Limited1.0571410812.2336
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited0.995492132.1033
Domestic EquitiesOrchid Pharma Limited0.8279362581.7493
Domestic EquitiesShilpa Medicare Limited0.8185495681.7294
Domestic EquitiesStandard Engineering Technology Ltd0.81681633571.7259
Domestic EquitiesCaplin Point Laboratories Limited0.7442104491.5724
Domestic EquitiesZydus Lifesciences Limited0.6923167921.4629
Domestic EquitiesAstraZeneca Pharma India Limited0.690918801.4599
Domestic EquitiesPoly Medicure Limited0.6789120441.4346
Domestic EquitiesSupriya Lifescience Limited0.6746253701.4255
Domestic EquitiesSyngene International Limited0.4118223150.8701
Total 99.1952 209.5985
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)0.8048 1.7006
Total 0.8048 1.7006
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.